Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
Eur J Cancer Care (Engl)
; 26(6)2017 Nov.
Article
in En
| MEDLINE
| ID: mdl-28557060
Key words
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Genetic Testing
/
Receptor Protein-Tyrosine Kinases
/
Carcinoma, Large Cell
/
Carcinoma, Non-Small-Cell Lung
/
ErbB Receptors
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Cancer Care (Engl)
Year:
2017
Document type:
Article